View digital versions
of our magazines
exactly as they
appear in print

International Clinical Trials
International Clinical Trials
ICT is a specialist journal designed to provide global coverage of key topics pertinent to the clinical trials sector.
European Biopharmaceutical Review
European Biopharmaceutical Review
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
Pharmaceutical Manufacturing and Packing Sourcer
Pharmaceutical Manufacturing and Packing Sourcer
PMPS is a specialist journal designed to provide worldwide coverage of a range of topics relating to the pharmaceutical manufacturing and packaging sector.
Innovations in Pharmaceutical Technology
Innovations in Pharmaceutical Technology
IPT was launched in 1997 to provide the pharmaceutical industry with quality information on the latest cutting-edge technologies.
European Pharmaceutical Contractor
European Pharmaceutical Contractor
The EPC edition is designed to fill a unique position in pharmaceutical contractor publishing.
Business Intelligence

BI the Way

Access to critical study information through actionable visual business intelligence reports can yield considerable benefits to clinical trial performance and timelines, aiding decision-making and helping turn sites into high achievers. Craig Morgan at goBalto explains.
Drug Development

Early-Stage Development

The EMA's new Adaptive Pathways Network – designed to support early patient access to new medicines in areas of high unmet medical need – could significantly lower drug development costs, claims Karine Kleinhaus at Pluristem Therapeutics.
Q&A: Sterile Sealing

Unstoppable Packaging

Pharma packaging is seeing a growth in the delivery of high-value injectable drugs, with stoppers playing a vital role in this, says Aptar Stelmi's Arnaud Fournier.
Legal & Regulatory
Patent Protection

Optional Extras

It is uncertain times for patent portfolios in Europe, with pharma companies large and small working out whether to opt in or out of the Unifi ed Patent Court system, coming in 2017. The risks, rewards and – crucially – costs of the new regime must all be weighed up, says Paul Harris at Pillsbury Law.



Website design and development by Rubler Studio
spacer Banner of Webinars.homepage on Samedan

Member login

E-mail address:

Remember me

News and Press Releases

Sir Ranulph Fiennes visits Source BioScience for the opening of the world’s first -70°C walk-in chamber

More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models


For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

Industry Events


21-24 June 2016, Munich

AUTOMATICA is an international trade fair for robotics and automation, covering all industrial and non-industrial application fields.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement